5 Dividend ETFs Outperforming the S&P 500
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 10 2025
0mins
Should l Buy FDS?
Source: Barron's
- Dividend Performance: This year has been challenging for dividends overall, but certain dividend funds are performing exceptionally well.
- Investment Strategy: The key to success lies in knowing where to invest and which funds to choose for optimal dividend returns.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FDS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FDS
Wall Street analysts forecast FDS stock price to rise
12 Analyst Rating
1 Buy
7 Hold
4 Sell
Hold
Current: 211.790
Low
253.00
Averages
295.91
High
326.00
Current: 211.790
Low
253.00
Averages
295.91
High
326.00
About FDS
FactSet Research Systems Inc. is a global financial digital platform and enterprise solutions provider. The Company's solutions deliver financial data, analytics, and open technology to global clients, including individual users. Its segments include the Americas, EMEA and Asia Pacific. It provides financial data and market intelligence on securities, companies, industries and people to enable its clients to research investment ideas and analyze, monitor and manage their portfolios. It supports various workflows, including investment research, quantitative research, portfolio management and trading, portfolio analytics, wealth management, ESG investing solutions, industry analysis and data solutions. It provides open and flexible technology offerings, including a configurable desktop and mobile platform, and comprehensive data feeds. Its technology also includes LogoIntern, a workflow tool to streamline the task of adding, organizing, and formatting logos into pitch decks.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Propel Holdings Reports Q1 Adjusted Income Decline
- Adjusted Income Decline: Propel Holdings reported a drop in first-quarter adjusted income despite an overall revenue increase, indicating challenges in profitability that could impact investor confidence.
- Market Reaction: The decline in income has raised concerns about Propel Holdings' future performance, potentially leading to stock price volatility and affecting the company's ability to raise capital in the market.
- Need for Strategic Adjustment: The company must reassess its business strategy to address the pressures from declining income, ensuring long-term sustainable growth and enhancing shareholder value.
- Investor Focus: Investors should closely monitor Propel Holdings' upcoming earnings reports and strategic adjustments to evaluate the potential for restoring profitability and market competitiveness.
See More
Radian Group Reports Q1 Non-GAAP Net Income
- Financial Performance: Radian Group reported a fiscal Q1 non-GAAP net income of $1.27 per diluted share late Wednesday, indicating the company's stable profitability amidst economic fluctuations.
- Market Reaction: This earnings figure may positively influence investor confidence, particularly in the current economic climate, showcasing the company's effective strategies in risk management and profitability.
- Strategic Significance: Radian Group's earnings performance highlights its ongoing competitiveness in the insurance and mortgage markets, potentially attracting more investor interest in its future growth prospects.
- Future Outlook: As market conditions evolve, Radian Group may continue to adjust its business strategies to maintain profitability and address potential market challenges.
See More
Flowco Reports Q1 Earnings Decline
- Earnings Decline: Flowco (FLOC) reported Q1 earnings of $0.23 per diluted share, down from $0.24 a year earlier, indicating pressure on profitability that may affect investor confidence.
- Market Reaction Cautious: The decline in earnings has led to a cautious market outlook for Flowco's future performance, potentially resulting in stock price volatility, prompting investors to monitor the company's strategic adjustments and market responses closely.
- Intensified Competition: The earnings drop in a highly competitive market suggests that Flowco may be facing challenges in market share and customer retention, necessitating effective measures to restore growth.
- Uncertain Future Outlook: The company did not provide specific future earnings guidance, and the lack of a clear growth strategy may raise concerns among investors regarding its long-term development prospects, impacting its performance in the capital markets.
See More
Alphatec Reports Breakeven Q1 Non-GAAP Results
- Performance Shift: Alphatec reported breakeven non-GAAP results for Q1, indicating a successful transition from previous losses, which reflects an improvement in its financial condition.
- Market Reaction: Despite not achieving profitability, the market's neutral response to the breakeven results suggests cautious optimism among investors regarding the company's future growth potential.
- Strategic Adjustments: The company may have achieved breakeven through operational optimization and cost control measures, demonstrating its adaptability in the current economic environment.
- Future Outlook: As market demand gradually recovers, Alphatec is positioned to potentially achieve profitability in upcoming quarters, further solidifying its market position in the medical device industry.
See More
Workiva Reports Significant Q1 Adjusted Earnings Growth
- Significant Earnings Growth: Workiva reported adjusted earnings of $0.77 per diluted share for Q1, a substantial increase from $0.14 in the same period last year, indicating a strong performance and notable improvement in profitability.
- Positive Market Reaction: This earnings growth exceeded market expectations, likely boosting investor confidence and potentially driving up the company's stock price, reflecting optimism about its future growth potential.
- Effective Strategic Execution: By optimizing its product offerings and enhancing customer service, the company successfully attracted more clients, driving sustained revenue growth and demonstrating effective strategic execution and market adaptability.
- Optimistic Future Outlook: With ongoing investments in technological innovation and market expansion, the company is expected to further enhance its market share and profitability, solidifying its leadership position in the industry.
See More
TransMedics Reports Q1 Adjusted Net Income
- Financial Performance: TransMedics reported an adjusted net income of $0.30 per diluted share for Q1, indicating financial stability, although market expectations for future growth remain to be seen.
- Market Reaction: The release of this earnings report may influence investor sentiment and stock price movements, particularly in the increasingly competitive medical device sector, where TransMedics must continuously demonstrate profitability to attract further investment.
- Strategic Implications: As the company gradually expands its market share in the organ transplant field, the Q1 earnings performance could support subsequent capital operations and R&D investments, enhancing its competitive position in the industry.
- Future Outlook: Despite the current positive financial data, TransMedics must remain vigilant regarding market dynamics and technological innovations to ensure it maintains a leading position in the rapidly evolving healthcare market.
See More
Propel Holdings Reports Q1 Adjusted Income Decline
- Adjusted Income Decline: Propel Holdings reported a drop in first-quarter adjusted income despite an overall revenue increase, indicating challenges in profitability that could impact investor confidence.
- Market Reaction: The decline in income has raised concerns about Propel Holdings' future performance, potentially leading to stock price volatility and affecting the company's ability to raise capital in the market.
- Need for Strategic Adjustment: The company must reassess its business strategy to address the pressures from declining income, ensuring long-term sustainable growth and enhancing shareholder value.
- Investor Focus: Investors should closely monitor Propel Holdings' upcoming earnings reports and strategic adjustments to evaluate the potential for restoring profitability and market competitiveness.
See More
Radian Group Reports Q1 Non-GAAP Net Income
- Financial Performance: Radian Group reported a fiscal Q1 non-GAAP net income of $1.27 per diluted share late Wednesday, indicating the company's stable profitability amidst economic fluctuations.
- Market Reaction: This earnings figure may positively influence investor confidence, particularly in the current economic climate, showcasing the company's effective strategies in risk management and profitability.
- Strategic Significance: Radian Group's earnings performance highlights its ongoing competitiveness in the insurance and mortgage markets, potentially attracting more investor interest in its future growth prospects.
- Future Outlook: As market conditions evolve, Radian Group may continue to adjust its business strategies to maintain profitability and address potential market challenges.
See More
Flowco Reports Q1 Earnings Decline
- Earnings Decline: Flowco (FLOC) reported Q1 earnings of $0.23 per diluted share, down from $0.24 a year earlier, indicating pressure on profitability that may affect investor confidence.
- Market Reaction Cautious: The decline in earnings has led to a cautious market outlook for Flowco's future performance, potentially resulting in stock price volatility, prompting investors to monitor the company's strategic adjustments and market responses closely.
- Intensified Competition: The earnings drop in a highly competitive market suggests that Flowco may be facing challenges in market share and customer retention, necessitating effective measures to restore growth.
- Uncertain Future Outlook: The company did not provide specific future earnings guidance, and the lack of a clear growth strategy may raise concerns among investors regarding its long-term development prospects, impacting its performance in the capital markets.
See More
Alphatec Reports Breakeven Q1 Non-GAAP Results
- Performance Shift: Alphatec reported breakeven non-GAAP results for Q1, indicating a successful transition from previous losses, which reflects an improvement in its financial condition.
- Market Reaction: Despite not achieving profitability, the market's neutral response to the breakeven results suggests cautious optimism among investors regarding the company's future growth potential.
- Strategic Adjustments: The company may have achieved breakeven through operational optimization and cost control measures, demonstrating its adaptability in the current economic environment.
- Future Outlook: As market demand gradually recovers, Alphatec is positioned to potentially achieve profitability in upcoming quarters, further solidifying its market position in the medical device industry.
See More
Workiva Reports Significant Q1 Adjusted Earnings Growth
- Significant Earnings Growth: Workiva reported adjusted earnings of $0.77 per diluted share for Q1, a substantial increase from $0.14 in the same period last year, indicating a strong performance and notable improvement in profitability.
- Positive Market Reaction: This earnings growth exceeded market expectations, likely boosting investor confidence and potentially driving up the company's stock price, reflecting optimism about its future growth potential.
- Effective Strategic Execution: By optimizing its product offerings and enhancing customer service, the company successfully attracted more clients, driving sustained revenue growth and demonstrating effective strategic execution and market adaptability.
- Optimistic Future Outlook: With ongoing investments in technological innovation and market expansion, the company is expected to further enhance its market share and profitability, solidifying its leadership position in the industry.
See More
TransMedics Reports Q1 Adjusted Net Income
- Financial Performance: TransMedics reported an adjusted net income of $0.30 per diluted share for Q1, indicating financial stability, although market expectations for future growth remain to be seen.
- Market Reaction: The release of this earnings report may influence investor sentiment and stock price movements, particularly in the increasingly competitive medical device sector, where TransMedics must continuously demonstrate profitability to attract further investment.
- Strategic Implications: As the company gradually expands its market share in the organ transplant field, the Q1 earnings performance could support subsequent capital operations and R&D investments, enhancing its competitive position in the industry.
- Future Outlook: Despite the current positive financial data, TransMedics must remain vigilant regarding market dynamics and technological innovations to ensure it maintains a leading position in the rapidly evolving healthcare market.
See More
